Abbott Laboratories to Separate Nutrition Business Into Independent, Publicly Traded Company

07:38 AM EDT, 10/21/2026 (MT Newswires) -- Abbott Laboratories (ABT) said Wednesday it intends to separate its Nutrition business into an independent, publicly traded company with about $8.5 billion in annual sales. Established Pharmaceuticals and Nutritional Products President Daniel Salvadori will become chief executive of the new company, Abbott said. Once the separation is complete, expected by the end of 2027, Abbott shareholders will own shares in both Abbott and the new independent company, Abbott said.